Is Inflammatory Micronucleation the Key to a Successful Anti-Mitotic Cancer Drug?

Open Biology - United Kingdom
doi 10.1098/rsob.170182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Royal Society

Related search

Successful Transition From Pediatric to Adult Care in Inflammatory Bowel Disease: What Is the Key?

Intestinal Research
Gastroenterology
2019English

Nonsteroidal Anti-Inflammatory Drug Use Is Associated With Cancer Risk Reduction in Chronic Dialysis Patients

Kidney International
Nephrology
2013English

A Key to Successful Immunotherapy.

Practica Otologica
Otorhinolaryngology
1993English

TNF-α Is a Key Regulator of MUC1, an Anti-Inflammatory Molecule, During AirwayPseudomonas aeruginosaInfection

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2011English

Risk of Microsatellite-Unstable Colorectal Cancer Is Associated Jointly With Smoking and Nonsteroidal Anti-Inflammatory Drug Use

Cancer Research
Cancer ResearchOncology
2006English

Ecballium Elaterium; A Possible Topical Anti-Inflammatory Drug

Bulletin of Pharmaceutical Sciences
PharmacologyPharmaceutical Science
2003English

How Do Anti-Mitotic Drugs Kill Cancer Cells?

Journal of Cell Science
Cell Biology
2009English

Anti-Inflammatory and Anti-Oxidant Properties: Is There a Link?

International Journal of Risk and Safety in Medicine
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Nonsteroidal Anti‐inflammatory Drug Use Is Associated With Incident Hypertension in Ankylosing Spondylitis

Arthritis Care and Research
Rheumatology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy